MedPath

Mupirocin

These highlights do not include all the information needed to use MUPIROCIN CREAM safely and effectively. See full prescribing information for MUPIROCIN CREAM. MUPIROCIN cream, for topical use Initial U.S. Approval: 1987

Approved
Approval ID

cb085bdf-e371-6e8a-e053-2995a90ae358

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 8, 2023

Manufacturers
FDA

Encube Ethicals Private Limited

DUNS: 915834105

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Mupirocin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21922-029
Application NumberANDA213076
Product Classification
M
Marketing Category
C73584
G
Generic Name
Mupirocin
Product Specifications
Route of AdministrationTOPICAL
Effective DateAugust 31, 2021
FDA Product Classification

INGREDIENTS (8)

GLYCERYL MONO AND DIPALMITOSTEARATEInactive
Code: KC98RO82HJ
Classification: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
POLYOXYL 20 CETOSTEARYL ETHERInactive
Code: YRC528SWUY
Classification: IACT
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT
PHENOXYETHANOLInactive
Code: HIE492ZZ3T
Classification: IACT
XANTHAN GUMInactive
Code: TTV12P4NEE
Classification: IACT
MUPIROCIN CALCIUMActive
Quantity: 2 g in 100 g
Code: RG38I2P540
Classification: ACTIM
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Mupirocin - FDA Drug Approval Details